Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Return on Invested Capital (2023 - 2025)

Historic Return on Invested Capital for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q3 2025 value amounting to 0.7%.

  • Indivior Pharmaceuticals' Return on Invested Capital changed N/A to 0.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.7%, marking a year-over-year change of. This contributed to the annual value of 0.31% for FY2024, which is 3000.0% up from last year.
  • Indivior Pharmaceuticals' Return on Invested Capital amounted to 0.7% in Q3 2025.
  • Indivior Pharmaceuticals' 5-year Return on Invested Capital high stood at 0.25% for Q1 2025, and its period low was 0.7% during Q3 2025.
  • Its 3-year average for Return on Invested Capital is 0.31%, with a median of 0.42% in 2023.
  • As far as peak fluctuations go, Indivior Pharmaceuticals' Return on Invested Capital skyrocketed by 2600bps in 2024, and later soared by 3200bps in 2025.
  • Quarter analysis of 3 years shows Indivior Pharmaceuticals' Return on Invested Capital stood at 0.5% in 2023, then soared by 85bps to 0.07% in 2024, then crashed by -860bps to 0.7% in 2025.
  • Its Return on Invested Capital stands at 0.7% for Q3 2025, versus 0.5% for Q2 2025 and 0.25% for Q1 2025.